Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Glioma × Resistance Training × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Motor Activity 26 Breast Neoplasms 20 Neoplasms 14 Prostatic Neoplasms 10 Obesity 7 Colorectal Neoplasms 6 Pancreatic Neoplasms 5 Sarcopenia 4 Polycystic Ovary Syndrome 4 Lung Neoplasms 4 Head and Neck Neoplasms 4 Multiple Myeloma 3 Lymphedema 3 Fatigue 3 Colonic Neoplasms 3 Brain Neoplasms 3 Uterine Cervical Neoplasms 2 Signs and Symptoms 2 Pharyngeal Neoplasms 2 Overweight 2 Lymphoma 2 Leukemia 2 Laryngeal Neoplasms 2 Insulin Resistance 2 Inflammation 2 Endometrial Neoplasms 2 Diabetes Mellitus, Type 2 2 Cachexia 2 Weight Loss 1 Uterine Neoplasms 1

Interventions

Temozolomide 99 Magnetic Resonance Spectroscopy 46 Bevacizumab 46 Radiotherapy 41 Irinotecan 23 Blood Specimen Collection 15 Aminolevulinic Acid 15 Surgical Procedures, Operative 13 Radiation 13 Carboplatin 13 Nivolumab 12 fluorodopa F 18 10 Radiotherapy, Intensity-Modulated 10 Radiosurgery 10 Carmustine 10 pembrolizumab 9 Topotecan 9 Surveys and Questionnaires 8 Specimen Handling 8 Magnetic Resonance Imaging 8 Erlotinib Hydrochloride 8 Biopsy 8 poly ICLC 7 Standard of Care 7 Filgrastim 7 Everolimus 7 Etoposide 7 Drug Therapy 7 Cyclophosphamide 7 ribociclib 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03775369 2022-05-18

Glioma and Exercising

University Hospital, Basel, Switzerland

Phase NA Completed

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡